Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Healthcare

Nanosonics Surges 13% After FDA Approval for CORIS System

Shares of Australian infection prevention company Nanosonics Ltd (ASX:NAN) soared 13% on Thursday, reaching a 52-week high of AU$4.95. The surge comes after the company announced a major milestone: U.S. Food and Drug Administration (FDA) De Novo clearance for its CORIS system, a groundbreaking …

Team Kalkine | 20 March 2025

Imugene Shares Surge 11% on Key FDA Fast Track Approval

Shares of Imugene Ltd (ASX:IMU) soared on Wednesday, gaining 11% to 3.9 cents after the clinical-stage immuno-oncology company secured a major regulatory milestone in the United States. The rally comes despite broader market weakness, with the All Ordinaries Index falling 0.4% in early trade.

Team Kalkine | 19 March 2025
Support

Hi! How can we help you today?

Loading…